International journal of radiation oncology, biology, physics
Four-Year Feasibility and Safety Results of a Phase 1/2 Single-Arm Prospective Clinical Trial of Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy for Metachronous Oligometastatic Abdominopelvic Lymph Node and Soft Tissue Metastases.
Thomas P Howard, Tyler Walburn, Grant Benham, Sejal Chirmade, David D Yang, Victoria S Brennan, Daniel N Cagney, Bradley A McGregor, Mark M Pomerantz, Jonathan E Leeman, Zhaohui Han, Mai Anh Huynh
Published: 202610.1016/j.ijrobp.2026.01.002
Abstract
PURPOSE: Metachronous oligometastases may represent a favorable disease state for local therapy after prior curative treatment. Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy (SMART) provides precise targeting of nodal and soft tis…
Preview only. Read the full abstract at the source